Use of Hedgehog Pathway Inhibitors in Combination Therapy for Basal Cell Carcinoma: A Review and Narrative Synthesis
{{output}}
Background: Hedgehog pathway inhibitors (HHIs) target aberrant Hedgehog signaling as a treatment of basal cell carcinomas (BCCs) but are limited by poorly tolerated adverse events (AEs) and development of resistance. To address t... ...
